4.6 Article

Pyk2 and Src Mediate Signaling to CCL18-Induced Breast Cancer Metastasis

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 115, 期 3, 页码 596-603

出版社

WILEY
DOI: 10.1002/jcb.24697

关键词

CCL18; INTEGRIN; METASTASIS; Pyk2; Src

资金

  1. 973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]

向作者/读者索取更多资源

Pyk2 and Src phosphorylation is initiated by CCL18, which promotes breast cancer metastasis via its functional G protein-coupled receptor PITPNM3. However, the function of Pyk2 and Src in CCL18-induced breast cancer metastasis is poorly understood. Quantitative reverse-transcription polymerase chain reactions (qRT-PCRs), Western blot, boyden chamber assay, and adherence assay were performed to delineate the consequences of Pyk2/Src in CCL18-induced breast cancer cells. Co-immunoprecipitation and immunofluorescence were performed to analyze the interaction of proteins. Upon the binding of CCL18 to PITPNM3, Pyk2 translocates from the cytoplasm to the plasma membrane to form a stable complex with PITPNM3, subsequently activating Src kinase. Moreover, upon stimulation with CCL18, Pyk2 and Src become essential for integrin alpha5/beta1 clustering-dependent adherence, migration, and invasion. Pyk2 and Src are important in CCL18-induced breast cancer metastasis. J. Cell. Biochem. 115: 596-603, 2014. (c) 2013 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据